Usual dietary therapies of mitochondrial fatty acid oxidation disorders (FAO) are based on 3 strategies: * limitation of lipid intake in the diet; * supplementation of the diet with medium-chain triglycerides (MCT) for patients affected with disorders of long-chain FAO; * some specific supplementations (for example, L-carnitine). These strategies are often ineffective. The aim of the present study is to evaluate new therapeutic ways based on the underlying energetic defect observed in these disorders. The long-term goal is to develop efficient therapies of these disorders.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Strength tests
Timeframe: 24 months
Biological parameters (acylcarnitines profile, modifications of urinary organic acids)
Timeframe: 24 months
Clinical parameters (echocardiography)
Timeframe: 24 months